需要胰岛素治疗与外周动脉疾病患者腹股沟下旁路术结局的关系
基于血管质量倡议数据库(2007-2021)回顾性分析9686例因外周动脉疾病行腹股沟下旁路术的糖尿病患者,比较需要胰岛素治疗(IRDM,56%)与不需要胰岛素治疗(NIRDM)患者的结局。中位随访427天,IRDM患者围手术期并发症更高,粗率上主要肢体不良事件(MALE)和死亡更高;回归分析显示胰岛素需求(而非HbA1c)与MALE(HR=1.17 [1.06-1.29])和死亡(HR=1.28 [1.16-1.43])独立相关。
要点
- IRDM患者围手术期并发症显著高于NIRDM,但围手术期死亡率两组无差异。
- IRDM患者粗率上主要通畅率更低,大截肢、MALE和死亡率更高。
- 胰岛素需求(而非HbA1c)与MALE(HR=1.17)和死亡(HR=1.28)独立相关。
核心结论
- 胰岛素需求而非HbA1c与腹股沟下旁路术后MALE和生存显著相关。
- 根据术前胰岛素使用对糖尿病患者进行分层可能改善旁路手术结局预测。
研究设计与样本
- 回顾性分析血管质量倡议数据库2007-2021年因外周动脉疾病行腹股沟下旁路术的糖尿病患者。
- 排除透析或既往肾移植患者,比较IRDM与NIRDM的特征和结局。
- 共纳入9686例糖尿病患者,其中56%为IRDM。
主要发现
- IRDM患者较NIRDM更年轻,女性(P<0.01)、非裔美国人(P<0.01)和西班牙裔(P=0.031)比例更高,合并症更多且美国麻醉医师协会分级IV-V级比例更高。
- IRDM患者因慢性肢体威胁性缺血接受治疗的比例更高(P<0.001)。
- IRDM患者围手术期并发症显著更高,但围手术期死亡率两组无差异。
- 平均随访427天,IRDM患者粗率上主要通畅率更低,大截肢、MALE和死亡率更高。
- 回归分析显示胰岛素需求与MALE(HR=1.17 [1.06-1.29])和死亡(HR=1.28 [1.16-1.43])独立相关,HbA1c无此关联。
临床怎么用
- 作者认为根据术前胰岛素使用对糖尿病患者进行分层可能改善腹股沟下旁路手术结局预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetes mellitus (DM) is a major risk factor for peripheral artery disease. The association of DM with major adverse limb events (MALE) after lower extremity revascularization remains controversial, as patients with diabetes are typically analyzed as a single, homogenous group. Using a large national database, this study examines the impact of insulin use and glycemic control on the outcomes following infrainguinal bypass. The hypothesis is that prevalent insulin therapy and elevated hemoglobin A1c (HbA1c) are associated with an increased risk of MALEs after infrainguinal bypass in patients with DM and could therefore be used for risk stratification. METHODS: The Vascular Quality Initiative database files for infrainguinal bypass (2007-2021) were retrospectively reviewed. Patients with DM undergoing bypass for peripheral artery disease were included. Patients on dialysis or with prior kidney transplantation were excluded. The characteristics and outcomes of patients with insulin-requiring diabetes mellitus (IRDM) were compared to those of patients not requiring insulin (noninsulin-requiring diabetes mellitus [NIRDM]) prior to the bypass procedure. RESULTS: A total of 9,686 patients with DM (56% IRDM) underwent bypass. Patients with IRDM were significantly younger than patients with NIRDM, more likely to be female (P < 0.01), African American (P < 0.01), and Hispanic (P = 0.031), and more likely to have comorbidities and be categorized into American Society of Anesthesiologist classes IV-V. They were more likely to be treated for chronic limb-threatening ischemia (P < 0.001). Patients with IRDM had significantly higher perioperative complications with no difference in perioperative mortality between the 2 groups. Beyond the perioperative period, with a mean follow-up of 427 days, patients with IRDM had significantly lower crude rates of primary patency and higher crude rates of major amputation, MALE, and mortality compared to patients with NIRDM. Regression analyses demonstrated that insulin requirement, but not HbA1c, was independently associated with a higher risk of MALE (hazard ratio = 1.17 [1.06-1.29]) and mortality (hazard ratio = 1.28 [1.16-1.43]). CONCLUSIONS: Insulin requirement, but not HbA1c, is significantly associated with MALEs and survival after infrainguinal bypass in the Vascular Quality Initiative. Stratification of patients with DM based on their prevalent insulin use prior to infrainguinal bypass surgery could improve the prediction of outcomes of peripheral arterial bypass surgery in patients with diabetes.
引用
- Alameddine D, Satam K, Slade M, et al. Insulin Requirement and Infrainguinal Bypass Outcomes in Patients with Peripheral Arterial Disease. Ann Vasc Surg. 2024. PMID: 38307234. doi:10.1016/j.avsg.2023.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。